CAS: 1386874-06-1
![2H-Imidazo[4,5-c]quinolin-2-one, 1,3-dihydro-8-[5-(1-hydroxy-1-methylethyl)-3-pyridinyl]-1-[(2S)-2…](https://static.cymitquimica.com/products/IN/thumb/DA001900.jpg)
2H-Imidazo[4,5-c]quinolin-2-one, 1,3-dihydro-8-[5-(1-hydroxy-1-methylethyl)-3-pyridinyl]-1-[(2S)-2-methoxypropyl]-3-methyl-
CAS:1386874-06-1
Formula:
C23H26N4O3
Purity:
98%
Color and Shape:
Solid
Molecular weight:
406.4775
Ref: IN-DA001900
| 10mg | 149.00 € | ||
| 25mg | 293.00 € |
Estimated delivery in United States, on Tuesday 7 Jan 2025
Samotolisib
CAS:1386874-06-1
Samotolisib (LY3023414) inhibits PI3K, DNA-PK, mTOR; tested for solid tumors including breast and colon cancer.
Formula:
C23H26N4O3
Purity:
98.41% - 99.69%
Color and Shape:
Solid
Molecular weight:
406.48
Ref: TM-T6883
| 5mg | 48.00 € | ||
| 10mg | 75.00 € | ||
| 25mg | 149.00 € | ||
| 50mg | 250.00 € | ||
| 100mg | 368.00 € | ||
| 200mg | 523.00 € | ||
| 1mL*10mM (DMSO) | 51.00 € |
Estimated delivery in United States, on Tuesday 14 Jan 2025
Samotolisib
CAS:1386874-06-1
Samotolisib is a novel drug that has been shown to inhibit tumor growth in vivo. …
Formula:
C23H26N4O3
Purity:
Min. 95%
Molecular weight:
406.48 g/mol
Ref: 3D-LFC87406
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Tuesday 18 Feb 2025
